Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(2',3-dimethyl-(2,4'-bipyridin)-5-yl)-n-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide
2. Lgk-974
3. Lgk974
4. Wnt-974
5. Wnt974
1. 1243244-14-5
2. Lgk974
3. Lgk-974
4. Wnt-974
5. Wnt974
6. Lgk 974
7. Chebi:78030
8. Lgk974 (wnt974)
9. Chembl3188386
10. U27f40013q
11. 2-[5-methyl-6-(2-methyl-4-pyridyl)-3-pyridyl]-n-(5-pyrazin-2-yl-2-pyridyl)acetamide
12. 2-[5-methyl-6-(2-methylpyridin-4-yl)pyridin-3-yl]-n-(5-pyrazin-2-ylpyridin-2-yl)acetamide
13. [2,4'-bipyridine]-5-acetamide, 2',3-dimethyl-n-[5-(2-pyrazinyl)-2-pyridinyl]-
14. 2-(2',3-dimethyl-(2,4'-bipyridin)-5-yl)-n-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide
15. 2-(2',3-dimethyl-2,4'-bipyridin-5-yl)-n-[5-(pyrazin-2-yl)pyridin-2-yl]acetamide
16. 2-[(2p)-2',3-dimethyl[2,4'-bipyridin]-5-yl]-n-[(5p)-5-(pyrazin-2-yl)pyridin-2-yl]acetamide
17. Unii-u27f40013q
18. (2,4'-bipyridine)-5-acetamide, 2',3-dimethyl-n-(5-(2-pyrazinyl)-2-pyridinyl)-
19. O50
20. Porcn Inhibitor Iv
21. Nvp-lgk974
22. Mls006011002
23. Schembl1723611
24. Wnt-974 [who-dd]
25. Gtpl11167
26. Hms3653g11
27. Bcp08495
28. Ex-a1402
29. Lgk-974 (wnt974)
30. Bbl102809
31. Bdbm50133870
32. Cs3177
33. Mfcd27501026
34. Nsc777639
35. S7143
36. Stl556617
37. Zinc95930187
38. Akos025211913
39. Ccg-264701
40. Db12561
41. Nsc-777639
42. Sb19314
43. Ncgc00347950-01
44. Ncgc00347950-02
45. Ncgc00347950-07
46. Ncgc00347950-11
47. Ac-30231
48. Hy-17545
49. Ms-20504
50. Smr004702800
51. Sw211728-2
52. J3.551.731f
53. A890524
54. Au-004/43508401
55. J-005066
56. Q27147596
57. Lgk 974;lgk974; Wnt974; Wnt 974; Wnt-974
58. 2-(2',3-dimethyl-[2,4'-bipyridin]-5-yl)-n-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide;lgk974
| Molecular Weight | 396.4 g/mol |
|---|---|
| Molecular Formula | C23H20N6O |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 396.16985928 g/mol |
| Monoisotopic Mass | 396.16985928 g/mol |
| Topological Polar Surface Area | 93.6 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 560 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
ABOUT THIS PAGE
69
PharmaCompass offers a list of WNT974 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right WNT974 manufacturer or WNT974 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred WNT974 manufacturer or WNT974 supplier.
PharmaCompass also assists you with knowing the WNT974 API Price utilized in the formulation of products. WNT974 API Price is not always fixed or binding as the WNT974 Price is obtained through a variety of data sources. The WNT974 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A WNT974 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of WNT974, including repackagers and relabelers. The FDA regulates WNT974 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. WNT974 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A WNT974 supplier is an individual or a company that provides WNT974 active pharmaceutical ingredient (API) or WNT974 finished formulations upon request. The WNT974 suppliers may include WNT974 API manufacturers, exporters, distributors and traders.
WNT974 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of WNT974 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right WNT974 GMP manufacturer or WNT974 GMP API supplier for your needs.
A WNT974 CoA (Certificate of Analysis) is a formal document that attests to WNT974's compliance with WNT974 specifications and serves as a tool for batch-level quality control.
WNT974 CoA mostly includes findings from lab analyses of a specific batch. For each WNT974 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
WNT974 may be tested according to a variety of international standards, such as European Pharmacopoeia (WNT974 EP), WNT974 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (WNT974 USP).
